Preclinical Studies Early preclinical studies in rodent obesity models demonstrated that AOD9604 administration reduced body weight and fat mass without affecting food intake, indicating a direct metabolic effect rather than an appetite-suppressing mechanism
In severe forms, the drug is administered intramuscularly, intravenously slowly or by infusion in saline 50-200 ml, 1200 mg per day, for 10-20 days
Serious and rarer side effects can include muscle cramping, irregular heartbeat, shortness of breath, slurred speech, vision changes, chest pain and weakness on one side of the body
This small section is then connected to the middle section of the small intestine, known as the jejunum
$74.99 Sale
You can book it for the face, the face and neck, or the face, neck and chest